Quantifying the impact of immortal time bias: empirical evidence from meta-analyses
Journal of the Royal Society of Medicine · 2025-09 · 118 (9) · 293-303
DOI: 10.1177/01410768251366880 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of the Royal Society of Medicine, online erschienen am 21.08.2025. Verfasst von Min Seo Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul 06351, Republic of Korea. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
Immortal time bias (ITB) occurs when a period during which, by design, participants cannot experience the outcome (like death) is incorrectly included in the treatment group’s follow-up, artificially making the treatment look better than it truly is. We aimed to identify a systematic sample of cases of ITB in the literature of studies using survival analysis and assess the impact of ITB on the results.
Design
Meta-epidemiological study (PROSPERO[CRD42022356073]).
Setting
We searched PubMed/MEDLINE, Embase and Cochrane Database of Systematic Reviews from database inception to August 2024. Systematic reviews with quantitative syntheses that allowed subgroup analysis by the presence of ITB for any available exposure-outcome pairs (‘topics’) were eligible for inclusion.
Participants
Participants included in the systematic reviews. Main outcome measures Information on ITB and effect sizes (ESs) with 95% confidence interval for individual studies in forest plots were extracted to run re-analysis using generic inverse variance fixed- and random-effects methods. After extracting data, we conducted subgroup analysis by the presence of ITB for all available topics and assessed the impact of ITB on the heterogeneity ( I 2 ), vulnerability of evidence (or conclusion), statistical significance of the finding, and altering ES in favour of intervention/exposure.
Results
The median (interquartile range (IQR)) number of studies included for a topic was 6 (4–10). Across 25 topics (including 182 studies), 44.0% of the eligible studies (80 studies) were affected by ITB. Among the 21 topics where both studies with ITB and studies without ITB were available (four topics only had studies unaffected by ITB), 57.1% (12/21) demonstrated statistically significant results only in studies with ITB ( n = 11 topics) or only in studies without ITB (one topic). In 23.8% (5/21), the overall summary results changed from statistically significant to non-statistically significant or vice versa after excluding studies with ITB. The ratio of ES – summary ES from studies with ITB relative to summary ES from studies without ITB – was 0.71 (95% CI, 0.66-0.78), suggesting that the ES from studies with ITB was larger by an average of 29% in favour of the intervention/exposure. Excluding studies involving ITB reduced between-study heterogeneity ( I 2 ) by 21.4% on average.
Conclusions
ITB can be common among studies in some medical areas, and its presence may substantially inflate the ESs and lead to misleading, exaggerated evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul 06351, Republic of Korea.
- Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
- Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA 02114, USA.
- Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul 02447, Republic of Korea.
- Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon 16419, Republic of Korea.
- Department of Physical Education and Sport Sciences, Faculty of Literature and Human Sciences, Lorestan University, Khorramabad 68151-44316, Iran.
ORCID-Profile: Masoud Rahmati, Jae Il Shin
Zitieren
APA
Kim, M. S., Yon, D. K., Lee, S. W., Rahmati, M., Solmi, M., Carvalho, A. F., Koyanagi, A., Smith, L., Shin, J. I., & Ioannidis, J. P. (2025). Quantifying the impact of immortal time bias: empirical evidence from meta-analyses. Journal of the Royal Society of Medicine, 118(9), 293-303. https://doi.org/10.1177/01410768251366880
Vancouver
Kim MS, Yon DK, Lee SW, Rahmati M, Solmi M, Carvalho AF, et al. Quantifying the impact of immortal time bias: empirical evidence from meta-analyses. Journal of the Royal Society of Medicine. 2025;118(9):293-303. doi:10.1177/01410768251366880
BibTeX
@article{Kim2025,
author = {Kim, Min Seo and Yon, Dong Keon and Lee, Seung Won and Rahmati, Masoud and Solmi, Marco and Carvalho, Andre F and Koyanagi, Ai and Smith, Lee and Shin, Jae Il and Ioannidis, John Pa},
title = {Quantifying the impact of immortal time bias: empirical evidence from meta-analyses},
journal = {Journal of the Royal Society of Medicine},
year = {2025},
volume = {118},
number = {9},
pages = {293--303},
doi = {10.1177/01410768251366880}
}
EUVIMED